- Home
- ANIP vs NTB Comparison
ANIP vs NTB Comparison
Compare ANIP & NTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANIP
- NTB
- Stock Information
- Founded
- ANIP 2001
- NTB 1858
- Country
- ANIP United States
- NTB Bermuda
- Employees
- ANIP N/A
- NTB N/A
- Industry
- ANIP Biotechnology: Pharmaceutical Preparations
- NTB Commercial Banks
- Sector
- ANIP Health Care
- NTB Finance
- Exchange
- ANIP Nasdaq
- NTB Nasdaq
- Market Cap
- ANIP 1.5B
- NTB 1.7B
- IPO Year
- ANIP N/A
- NTB 2016
- Fundamental
- Price
- ANIP $59.99
- NTB $42.86
- Analyst Decision
- ANIP Strong Buy
- NTB Buy
- Analyst Count
- ANIP 8
- NTB 4
- Target Price
- ANIP $80.13
- NTB $44.25
- AVG Volume (30 Days)
- ANIP 472.7K
- NTB 191.6K
- Earning Date
- ANIP 05-09-2025
- NTB 04-23-2025
- Dividend Yield
- ANIP N/A
- NTB 4.10%
- EPS Growth
- ANIP N/A
- NTB 7.68
- EPS
- ANIP N/A
- NTB 4.81
- Revenue
- ANIP $674,068,000.00
- NTB $585,277,000.00
- Revenue This Year
- ANIP $27.77
- NTB $3.10
- Revenue Next Year
- ANIP $7.88
- NTB $0.34
- P/E Ratio
- ANIP N/A
- NTB $8.93
- Revenue Growth
- ANIP 30.27
- NTB 1.89
- 52 Week Low
- ANIP $52.50
- NTB $32.78
- 52 Week High
- ANIP $73.72
- NTB $41.88
- Technical
- Relative Strength Index (RSI)
- ANIP 31.13
- NTB 71.18
- Support Level
- ANIP $68.50
- NTB $40.32
- Resistance Level
- ANIP $62.60
- NTB $43.09
- Average True Range (ATR)
- ANIP 3.13
- NTB 0.69
- MACD
- ANIP -1.50
- NTB 0.21
- Stochastic Oscillator
- ANIP 5.55
- NTB 91.19
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.
About NTB Bank of N.T. Butterfield & Son Limited (The) Voting
Bank of N.T Butterfield & Son Ltd is a full-service bank and wealth manager. It operates the business through three geographic segments, Bermuda, Cayman Islands, the Channel Islands and the UK. The company offers banking services, comprised of retail and corporate banking, and wealth management, which consists of trust, private banking, and asset management. The company generates a majority of its revenue from Bermuda, and the Cayman Islands segments.